Literature DB >> 30581130

Diagnosing Peanut Allergy with Fewer Oral Food Challenges.

Jennifer J Koplin1, Kirsten P Perrett2, Hugh A Sampson3.   

Abstract

Diagnosis of peanut allergy presents a significant clinical challenge. Accurate diagnosis is critical for patient management and prevention of allergic reactions, whereas overdiagnosis or failure to diagnose tolerance in a previously allergic patient can lead to unnecessary dietary restrictions and impaired quality of life. Oral food challenges, the criterion standard for diagnosis, pose a risk of potentially severe allergic reactions, and are time- and resource- intensive. In this article, we review other currently available tests for peanut allergy and present the strengths and weaknesses of each to assist the clinician in determining which test might be appropriate for their patients, as well as highlighting emerging tests currently in development. Traditional tests for peanut-specific IgE (skin prick testing and specific IgE) remain useful as first-line tests-a negative test result is useful for excluding peanut allergy and a high positive result has a high specificity for peanut allergy. For those with an intermediate positive test result, Ara h 2 testing might be useful as a second step. Basophil activation tests and peanut protein epitope-specific IgE analyses appear promising in recent studies; however, further research is required into standardization, validation, and cost-effectiveness. Given the limitations of existing tests for peanut allergy, there remains a clear need for improvement. Finding a safe and affordable method for peanut allergy diagnosis that is both sensitive and specific remains an active area of research.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basophil activation test; Diagnosis; Histamine release assay; Mast cell activation test; Peanut allergy; Skin prick test; Specific IgE

Year:  2018        PMID: 30581130     DOI: 10.1016/j.jaip.2018.11.010

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  5 in total

1.  Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE.

Authors:  Mindy Tsai; Kaori Mukai; R Sharon Chinthrajah; Kari C Nadeau; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2019-12-02       Impact factor: 10.793

2.  Validation of inducible basophil biomarkers: Time, temperature and transportation.

Authors:  Theodore Kim; Jing Yu; Henry Li; Mark Scarupa; Richard L Wasserman; Athena Economides; Martha White; Carla Ward; Atul Shah; Douglas Jones; Melinda Rathkopf; Kelly Frye; Ahmet Aybar; Shahrooz Shayegan; Benjamin Enav; Laura Ispas; Denise Loizou; David Fitzhugh; James Tracy; James Friedlander; Zachary Jacobs; Jonathan Matz; David Golden; Donald McNeil; William McCann; Christopher Copenhaver; Jeffrey Factor; Raavi Gupta; Oral Alpan; Matthew Plassmeyer; Søren Ulrik Sønder
Journal:  Cytometry B Clin Cytom       Date:  2021-02-04       Impact factor: 3.248

Review 3.  Current Controversies and Future Prospects for Peanut Allergy Prevention, Diagnosis and Therapies.

Authors:  Claudia Liesel Gray
Journal:  J Asthma Allergy       Date:  2020-01-16

4.  A study to assess current approaches of allergists in European countries diagnosing and managing children and adolescents with peanut allergy.

Authors:  Vibha Sharma; Jennifer Jobrack; Wendy Cerenzia; Stephen Tilles; Robert Ryan; Regina Sih-Meynier; Stefan Zeitler; Michael Manning
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

5.  Peanut components measured by ISAC: comparison with ImmunoCap and clinical relevance in peanut allergic children.

Authors:  H K Brand; M W J Schreurs; J A M Emons; R Gerth van Wijk; H de Groot; N J T Arends
Journal:  Clin Mol Allergy       Date:  2021-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.